Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stem cell collection for humanized xenograft studies in melanoma and HNSCC
NCT02331134Completed
- Sponsor
- University of Colorado Denver
- Start
- May 2015
- Primary completion
- Jul 2018
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Open-label trial of filgrastim in Malignant Melanoma (MM) and head and neck squamous cell carcinoma (HNSCC), sponsored by University of Colorado Denver. Primary endpoint: Tissue and Hematopoietic Stem Cell Collection. Started May 2015; status: completed.
02
Drugs
filgrastim
03
Conditions
Malignant Melanoma (MM)head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT02331134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02331134.